跳至主要内容
临床试验/ITMCTR2100005028
ITMCTR2100005028尚未招募1 期

A randomized, double-blind, parallel-controlled, multi-center clinical trial of the effectiveness and safety of Fuyanxiao Capsule in the treatment of pelvic inflammatory diseases (damp-heat stasis syndrome)

Dongfang Hospital, Beijing University of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
20 至 50(—)
性别
Female

入选标准

  • For a qualified subject, the answer to all the selection criteria must be yes.
  • 1.Meet the diagnostic criteria of Western medicine for pelvic inflammatory diseases;
  • 2.Patients who meet the TCM syndrome of damp-heat stasis;
  • 3.Aged 20 to 50 years, married or have a history of sexual life;
  • 4.45.Lower abdominal pain VAS >= 4 points;
  • 6.Axillary body temperature<=38.0?;
  • 7.The patient himself gave informed consent and signed the informed consent form.

排除标准

  • For a qualified subject, the answer to all exclusion criteria must be No:
  • 1.Combined with medical history and physical signs, auxiliary examinations include appendicitis, ectopic pregnancy, torsion of ovarian cyst pedicle, pelvic hemorrhage, rupture of ovarian cyst, gastroenteritis, sequelae of pelvic inflammatory disease, endometriosis, adenomyosis And related symptoms caused by Neisseria gonorrhoeae infection;
  • 2.Patients are pregnant, lactating or planning to become pregnant in the near future;
  • 3.Routine blood white blood cell count> 1.1 times the upper limit of normal, and blood routine neutrophil percentage> 90%;
  • 4.Patients are in critical condition or have surgical indications, such as complicated fallopian tube ovarian abscess, pelvic abscess, diffuse peritonitis, sepsis, etc.;
  • 5.Patients with serious primary diseases and mental illnesses of the heart, brain, liver, kidney, hematopoietic and immune systems;
  • 6.Patients have taken relevant Chinese and Western medicines for the treatment of this disease within 1 month before enrollment, and the curative effect of the medicine is difficult to judge;
  • 7.Patients are allergic to the drug components of the known test drugs;
  • 8.Alanine aminotransferase (ALT), aspartate aminotransferase (AST) greater than 1.2 times the upper limit of normal, and blood creatinine (Cr) greater than the upper limit of normal;
  • 9.Participate in other clinical studies within 1 month before screening.

研究者

发起方
Dongfang Hospital, Beijing University of Chinese Medicine

相似试验

尚未招募
不适用
A randomized, double-blind, parallel-controlled, multicenter trial to evaluate the effectiveness and safety of Xiyanping injection combined with azithromycin and azithromycin in the treatment of mycoplasma pneumoniae pneumonia in childreMycoplasma pneumoniae pneumonia
ITMCTR2000003093The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
招募中
4 期
A randomized, double-blind, parallel-controlled, multi-center clinical trial of Chinese medicine variety protection with Niuhuang Qinggan Capsule in the treatment of common cold (wind-heat syndrome)Common cold (wind-heat syndrome)
ITMCTR2200005537The Second Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine
招募中
4 期
A randomized, double-blind, parallel-controlled, multi-center clinical trial of traditional Chinese medicine variety protection with Wuhu Oral Liquid in the treatment of acute soft tissue injury (Qi stagnation and blood stasis syndrome)acute soft tissue injury
ITMCTR2200005606onghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
招募中
4 期
A randomized, double-blind, parallel-controlled, multicentre clinical study to evaluate the efficacy and safety of Sechang Zhixie Powder in the treatment of acute watery diarrhea in childreAcute watery diarrhea
ITMCTR2100004284First Teaching Hospital of Tianjin University of TCM
招募中
2 期
Phase II Clinical Trial of Qingke Pingchuan Granules in Treating Acute Bronchitis in ChildreAcute bronchitis in children
ITMCTR2100004581Shanghai Traditional Chinese Medicine Hospital